1887

Abstract

The emergence of G12 rotaviruses raises questions about the ability of candidate vaccines in providing protection against such emerging genotypes. Therefore, we assessed cross-neutralization against four reference rotavirus strains namely Wa (G1P[8]), DS-1 (G2P[4]), 116E (G9P[11]) and RV024 (G12P[6]) using paired sera from 28 children infected with G1P[8], G2P[4], G9P[6/8] or G12P[6] genotypes. Convalescent sera of G12P[6]-infected children demonstrated heterotypic response against 116E and Wa strains (50 and 33.3 %). In contrast, none of the four G2P[4]-infected children seroconverted against Wa or RV024 rotaviruses. The geometric mean neutralizing antibody titre in convalescent sera of G12P[6]-infected children was eightfold higher against strains belonging to the Wa genogroup (i.e. G1, G9 and G12 rotavirus) than against strains belonging to the DS-1 genogroup (G2 rotavirus). In conclusion, this study demonstrates that neutralization in part may be genogroup specific, and thus a monovalent vaccine based on the Wa genogroup is likely to protect against the G12 rotaviruses.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.019489-0
2010-07-01
2019-11-22
Loading full text...

Full text loading...

/deliver/fulltext/jgv/91/7/1794.html?itemId=/content/journal/jgv/10.1099/vir.0.019489-0&mimeType=html&fmt=ahah

References

  1. Arias, C. F., Lopez, S., Mascarenhas, J. D., Romero, P., Cano, P., Gabbay, Y. B., de Freitas, R. B. & Linhares, A. C. ( 1994; ). Neutralizing antibody immune response in children with primary and secondary rotavirus infections. Clin Diagn Lab Immunol 1, 89–94.
    [Google Scholar]
  2. Bahl, R., Ray, P., Subodh, S., Shambharkar, P., Saxena, M., Parashar, U., Gentsch, J., Glass, R. & Bhan, M. K. ( 2005; ). Incidence of severe rotavirus diarrhea in New Delhi, India, and G and P types of the infecting rotavirus strains. J Infect Dis 192, S114–S119.[CrossRef]
    [Google Scholar]
  3. Bernstein, D. I., Sack, D. A., Rothstein, E., Reisinger, K., Smith, V. E., O’Sullivan, D., Spriggs, D. R. & Ward, R. L. ( 1999; ). Efficacy of live, attenuated, human rotavirus vaccine 89–12 in infants: a randomised placebo-controlled trial. Lancet 354, 287–290.[CrossRef]
    [Google Scholar]
  4. Bhan, M. K., Lew, J. F., Sazawal, S., Das, B. K., Gentsch, J. R. & Glass, R. I. ( 1993; ). Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea. J Infect Dis 168, 282–287.[CrossRef]
    [Google Scholar]
  5. Bhandari, N., Sharma, P., Glass, R. I., Ray, P., Greenberg, H., Taneja, S., Saksena, M., Rao, C. D., Gentsch, J. R. & other authors ( 2006; ). Safety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and I321, in infants: results of a randomised controlled trial. Vaccine 24, 5817–5823.[CrossRef]
    [Google Scholar]
  6. Bhandari, N., Sharma, P., Taneja, S., Kumar, T., Rongsen-Chandola, T., Appaiahgari, M. B., Mishra, A., Singh, S. & Vrati, S. ( 2009; ). A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial. J Infect Dis 200, 421–429.[CrossRef]
    [Google Scholar]
  7. Brüssow, H., Clark, H. F. & Sidoti, J. ( 1991; ). Prevalence of serum neutralizing antibody to serotype 9 rotavirus WI61 in children from South America and central. J Clin Microbiol 29, 208–211.
    [Google Scholar]
  8. Choi, A. H., McNeal, M. M., Basu, M., Flint, J. A., Stone, S. C., Clements, J. D., Bean, J. A., Poe, S. A., VanCott, J. L. & Ward, R. L. ( 2002; ). Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses. Vaccine 20, 3310–3321.[CrossRef]
    [Google Scholar]
  9. Das, B. K., Gentsch, J. R., Cicirello, H. G., Woods, P. A., Gupta, A., Ramachandran, M., Kumar, R., Bhan, M. K. & Glass, R. I. ( 1994; ). Characterization of rotavirus strains from newborns in New Delhi, India. J Clin Microbiol 32, 1820–1822.
    [Google Scholar]
  10. Glass, R. I., Bhan, M. K., Ray, P., Bahl, R., Parashar, U. D., Greenberg, H., Rao, C. D., Bhandari, N., Maldonado, Y. & other authors ( 2005; ). Development of candidate rotavirus vaccines derived from neonatal strains in India. J Infect Dis 192, S30–S35.[CrossRef]
    [Google Scholar]
  11. Glass, R. I., Parashar, U. D., Bresee, J. S., Turcios, R., Fischer, T. K., Widdowson, M., Jiang, B. & Gentsch, J. R. ( 2006; ). Rotavirus vaccines: current prospects and future challenges. Lancet 368, 323–332.[CrossRef]
    [Google Scholar]
  12. Heaton, P. M., Goveia, M. G., Miller, J. M., Offit, P. & Clark, H. F. ( 2005; ). Development of a pentavalent rotavirus vaccine against prevalent serotypes of rotavirus gastroenteritis. J Infect Dis 192, S17–S21.[CrossRef]
    [Google Scholar]
  13. Hoshino, Y. & Kapikian, A. Z. ( 1996; ). Classification of rotavirus VP4 and VP7 serotypes. Arch Virol Suppl 12, 99–111.
    [Google Scholar]
  14. Hoshino, Y., Sereno, M. M., Midthun, K., Flores, J., Kapikian, A. Z. & Chanock, R. M. ( 1985; ). Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity. Proc Natl Acad Sci U S A 82, 8701–8704.[CrossRef]
    [Google Scholar]
  15. Jiang, B., Gentsch, J. R. & Glass, R. I. ( 2008; ). Inactivated rotavirus vaccines: a priority for accelerated vaccine development. Vaccine 26, 6754–6758.[CrossRef]
    [Google Scholar]
  16. Kirkwood, C. D. & Buttery, J. ( 2003; ). Rotavirus vaccines – an update. Expert Opin Biol Ther 3, 97–105.[CrossRef]
    [Google Scholar]
  17. Knowlton, D. R., Spector, D. M. & Ward, R. L. ( 1991; ). Development of an improved method for measuring neutralizing antibody to rotavirus. J Virol Methods 33, 127–134.[CrossRef]
    [Google Scholar]
  18. Kutsuzawa, T., Konno, T., Suzuki, H., Kapikian, A. Z., Ebina, T. & Ishida, N. ( 1982; ). Isolation of human rotavirus subgroups 1 and 2 in cell culture. J Clin Microbiol 16, 727–730.
    [Google Scholar]
  19. Malik, J., Bhan, M. K. & Ray, P. ( 2008; ). Natural immunity to rotavirus infection in children. Indian J Biochem Biophys 45, 219–228.
    [Google Scholar]
  20. Matthijnssens, J., Ciarlet, M., Heiman, E., Arijs, I., Delbeke, T., McDonald, S. M., Palombo, E. A., Iturriza-Gómara, M., Maes, P. & other authors ( 2008; ). Full genome-based classification of rotaviruses reveals a common origin between human Wa-like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains. J Virol 82, 3204–3219.[CrossRef]
    [Google Scholar]
  21. Offit, P. A. & Blavat, G. ( 1986; ). Identification of the two rotavirus genes determining neutralization specificities. J Virol 57, 376–378.
    [Google Scholar]
  22. Parashar, U. D., Gibson, C. J., Bresse, J. S. & Glass, R. I. ( 2006; ). Rotavirus and severe childhood diarrhea. Emerg Infect Dis 12, 304–306.[CrossRef]
    [Google Scholar]
  23. Rahman, M., Matthijnssens, J., Yang, X., Delbeke, T., Arijs, I., Taniguchi, K., Iturriza-Gomara, M., Iftekharuddin, N., Azim, T. & Van Ranst, M. ( 2007; ). Evolutionary history and global spread of the emerging G12 human rotaviruses. J Virol 81, 2382–2390.[CrossRef]
    [Google Scholar]
  24. Ramachandran, M., Vij, A., Kumar, R., Das, B. K., Gentsch, J. R., Bhan, M. K. & Glass, R. I. ( 1998; ). Lack of maternal antibodies to P serotypes may predispose neonates to infections with unusual rotavirus strains. Clin Diagn Lab Immunol 5, 527–530.
    [Google Scholar]
  25. Ray, P. G. & Kelkar, S. D. ( 2004; ). Prevalence of neutralizing antibodies against different rotavirus serotypes in children with severe rotavirus-induced diarrhea and their mothers. Clin Diagn Lab Immunol 11, 186–194.
    [Google Scholar]
  26. Ray, P., Sharma, S., Agarwal, R. K., Longmei, K., Gentsch, J. R., Paul, V. K., Glass, R. I. & Bhan, M. K. ( 2007; ). First detection of G12 rotaviruses in newborns with neonatal rotavirus infection at All India Institute of Medical Sciences, New Delhi, India. J Clin Microbiol 45, 3824–3827.[CrossRef]
    [Google Scholar]
  27. Ruiz-Palacios, G. M., Perez-Schael, I., Velazquez, F. R., Abate, H., Breuer, T., Clemens, S. C., Cheuvart, B., Espinoza, F., Gillard, P. & other authors ( 2006; ). Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354, 11–22.[CrossRef]
    [Google Scholar]
  28. Santos, N. & Hoshino, Y. ( 2005; ). Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 15, 29–56.[CrossRef]
    [Google Scholar]
  29. Schumann, T., Hotzel, H., Otto, P. & Johne, R. ( 2009; ). Evidence of interspecies transmission and reassortment among avian group A rotaviruses. Virology 386, 334–343.[CrossRef]
    [Google Scholar]
  30. Sharma, S., Ray, P., Gentsch, J. R., Glass, R. I., Kalra, V. & Bhan, M. K. ( 2008; ). Emergence of G12 rotavirus strains in Delhi, India, in 2000 to 2007. J Clin Microbiol 46, 1343–1348.[CrossRef]
    [Google Scholar]
  31. Sharma, S., Paul, V. K., Bhan, M. K. & Ray, P. ( 2009; ). Genomic characterization of nontypeable rotaviruses and detection of a rare G8 strain from Delhi, India. J Clin Microbiol 47, 3998–4005.[CrossRef]
    [Google Scholar]
  32. Uchida, R., Pandey, B. D., Sherchand, J. B., Ahmed, K., Yokoo, M., Nakagomi, T., Cuevas, L. E., Cunliffe, N. A., Hart, C. A. & Nakagomi, O. ( 2006; ). Molecular epidemiology of rotavirus diarrhea among children and adults in Nepal: detection of G12 strains with P[6] or P[8] and a G11P[25] strain. J Clin Microbiol 44, 3499–3505.[CrossRef]
    [Google Scholar]
  33. Ursu, K., Kisfali, P., Rigo, D., Ivanics, E., Erdelyi, K., Dan, A., Melegh, B., Martella, V. & Banyai, K. ( 2009; ). Molecular analysis of the VP7 gene of pheasant rotaviruses identifies a new genotype, designated G23. Arch Virol 154, 1365–1369.[CrossRef]
    [Google Scholar]
  34. Vesikari, T., Matson, D. O., Dennehy, P., Van Damme, P., Santosham, M., Rodriguez, Z., Dallas, M. J., Heyse, J. F., Goveia, M. G. & other authors ( 2006; ). Safety and efficacy of a pentavalent human–bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354, 23–33.[CrossRef]
    [Google Scholar]
  35. Ward, R. L., Sander, D. S., Schiff, G. M. & Bernstein, D. I. ( 1990; ). Effect of vaccination on serotype-specific antibody responses in infants administered WC3 bovine rotavirus before or after a natural rotavirus infection. J Infect Dis 162, 1298–1303.[CrossRef]
    [Google Scholar]
  36. Yu, J. & Langridge, W. H. ( 2001; ). A plant-based multicomponent vaccine protects mice from enteric diseases. Nat Biotechnol 19, 548–552.[CrossRef]
    [Google Scholar]
  37. Zheng, B. J., Han, S. X., Yan, Y. K., Liang, X. R., Ma, G. Z., Yang, Y. & Ng, M. H. ( 1988; ). Development of neutralizing antibodies and group A common antibodies against natural infections with human rotavirus. J Clin Microbiol 26, 1506–1512.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.019489-0
Loading
/content/journal/jgv/10.1099/vir.0.019489-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error